Europe / 16 country guides

Peptides in Europe: compare official medicine and pharmacy records country by country.

Europe is not one peptide market. This map connects 16 country guides and shows which official record answers the product question, which record answers the seller or supply question, and where a regional assumption must stop. Austria, Belgium, Denmark, and Finland add distinct national product and legal seller checks.

Regional boundary

One map, distinct national records.

European search results often collapse EU authorization, national market status, pharmacy licensing, online-selling authority, compounding, import, cosmetics, and laboratory materials into one result set. The useful comparison is the verification route in each country, not a region-wide verdict or seller ranking.

Verification sequence

Three checks before any regional comparison.

Use the same sequence in every country, while allowing the authority, terminology, available fields, and legal route to change.

01

Classify the offer before comparing it

Separate an authorized medicine, pharmacy or clinic service, compounded preparation, cosmetic, supplement, and laboratory material. A shared ingredient name does not make those categories interchangeable.

02

Resolve the product in the relevant record

Open the country guide and match the exact medicine or product record, including holder, form, strength, authorization, and current market status where the regulator publishes them.

03

Verify the seller and supply route separately

Use the national pharmacy, online-seller, establishment, or professional register linked by the country guide. A regional shipping claim or copied common logo does not replace that record.

Direct answers

What this regional map can and cannot answer.

These answers preserve the country boundary and point to the source map below. They are not medical or legal advice.

01

Are peptide rules the same across Europe?

No. Product authorization may involve European and national systems, but market status, pharmacy licensing, online supply, professional authority, import, and enforcement still require the country-specific records linked in this map.

02

Does a European pharmacy logo prove that a peptide product is authorized?

No. A linked common logo can help verify an online medicine seller where that system applies, but it does not by itself establish the authorization, presentation, prescription status, or current market status of the exact product being offered.

03

Does Peptide Local rank the best European peptide seller?

No. This regional page compares verification routes, not unlike seller categories. A commercial table would require sourced seller identity, product category, delivery market, exact price, evidence access, and observation date for every included row.

Tracked compound routes

41 peptide records, one country boundary.

These direct answers resolve the identity and status lane first. Select a destination country before drawing any conclusion about authorization, supply, or a seller.

01FDA-reviewed unapproved peptide identity

KPV in Europe

KPV in Europe is tracked as an FDA-reviewed unapproved peptide identity with preclinical evidence and no identified human administration study. This is not a region-wide authorization, availability, benefit, safety, or supply finding. Choose a destination country and verify its exact product and seller records.

02US research-market identity

BPC-157 in Europe

BPC-157 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

03US research-market identity

TB-500 in Europe

TB-500 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

04US research-market identity

GHK-Cu in Europe

GHK-Cu in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

05US research-market identity

Semax in Europe

Semax in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

06US research-market identity

Melanotan II in Europe

Melanotan II in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

07US research-market identity

MOTS-c in Europe

MOTS-c in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

08US research-market identity with a separate FDA-licensed medicine record

Tesamorelin in Europe

Tesamorelin in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

09US research-market identity with a failed oral obesity program and no FDA-approved drug

AOD-9604 in Europe

AOD-9604 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

10US research-market identity

Ipamorelin in Europe

Ipamorelin in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

11US research-market identity

Selank in Europe

Selank in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

12US research-market identity with a separate FDA-approved medicine record

PT-141 / Bremelanotide in Europe

PT-141 / Bremelanotide in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

13US research-market identity

CJC-1295 no DAC in Europe

CJC-1295 no DAC in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

14US research-market identity

CJC-1295 DAC in Europe

CJC-1295 DAC in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

15Investigational clinical program

Retatrutide in Europe

Retatrutide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.

16China-approved medicine and active clinical program

Mazdutide in Europe

Mazdutide has NMPA approvals in China, not a region-wide or worldwide approval for Europe. Verify the destination country's current product and seller records before treating any offer as authorized or available.

17China-approved medicine and active development program

Ecnoglutide in Europe

Ecnoglutide has NMPA approvals in China, not a region-wide or worldwide approval for Europe. Verify the destination country's current product and seller records before treating any offer as authorized or available.

18Investigational clinical program

Enicepatide in Europe

Enicepatide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.

19Investigational clinical program

Eloralintide in Europe

Eloralintide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.

20Investigational clinical program

Cagrilintide in Europe

Cagrilintide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.

21Investigational clinical program

Petrelintide in Europe

Petrelintide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.

22Investigational clinical program

CagriSema in Europe

CagriSema in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.

24Investigational clinical program

Survodutide in Europe

Survodutide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.

26Investigational clinical program

Pemvidutide in Europe

Pemvidutide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.

27Investigational clinical program

Amycretin / Zenagamtide in Europe

Amycretin / Zenagamtide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.

28US FDA medicine reference

Tirzepatide in Europe

Tirzepatide in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

29FDA-approved US medicine with country-specific status elsewhere

Orforglipron / Foundayo in Europe

Orforglipron / Foundayo in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

30Product-specific approved medicine records in multiple jurisdictions

Semaglutide in Europe

WEGOVY has an EU marketing authorization, but national prescription, reimbursement, presentation, launch, supply, pharmacy, and seller records still differ across Europe. Choose the destination country and verify its current records.

31FDA-flagged unapproved research-market peptide identity

DSIP / Emideltide in Europe

DSIP / Emideltide in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

32US research-market identity

IGF-1 LR3 in Europe

IGF-1 LR3 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

33US research-market identity

Kisspeptin-10 / KP-10 in Europe

Kisspeptin-10 / KP-10 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

34US research-market identity separated from SCENESSE

Melanotan I in Europe

Melanotan I in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

35US research-market non-peptide coenzyme identity

NAD+ in Europe

NAD+ in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

36US research-market identity with a withdrawn historical medicine record

Sermorelin in Europe

Sermorelin in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

37No FDA-approved US product; exact foreign prescription products exist

Thymosin Alpha-1 in Europe

Thymosin Alpha-1 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

38FDA-approved US medicine with a withdrawn EU application

EGRIFTA WR in Europe

EGRIFTA WR in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

39Product-specific FDA and EU medicine records

Liraglutide in Europe

Liraglutide in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

40Product-specific FDA and EU medicine records

SCENESSE in Europe

SCENESSE in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

41Product-specific FDA-approved US medicine record

VYLEESI in Europe

VYLEESI in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

Country record map

16 destinations, each with its own source trail.

Open the first source for the product question and the second source for the seller, pharmacy, establishment, or supply question. Read the full country guide for the exact boundary.

03

Peptide in Deutschland

Deutsch · 18. Juli 2026
Regulierter Arzneimittelmarkt

Ein quellenbasierter Deutschland-Leitfaden, der zugelassene Arzneimittel, erlaubten Versandhandel und Laborangebote getrennt betrachtet, bevor Preis oder Verfügbarkeit verglichen werden.

Comparison mode
EUR / Zulassung & Versandregister
Current price coverage
Keine Anbieter-Rangliste
Read the Deutschland guide
04

Péptidos en España

Español · 18 de julio de 2026
Mercado de medicamentos regulado

Una guía para España que separa el estado oficial del medicamento, la farmacia autorizada para venta a distancia y los materiales anunciados solo para investigación antes de comparar ofertas.

Comparison mode
EUR / CIMA, Distafarma y autorización
Current price coverage
Sin vendedores clasificados
Read the España guide
05

Peptidi in Italia

Italiano · 18 luglio 2026
I registri AIFA e ministeriali devono coincidere

Guida italiana all'uso della banca dati AIFA e dell'elenco ministeriale delle farmacie online prima di confrontare un prodotto o un venditore collegato ai peptidi.

Comparison mode
EUR / registri AIFA e Ministero della Salute
Current price coverage
Nessuna tabella qualificata di venditori in Italia
Read the Italia guide
06

Peptiden in Nederland

Nederlands · 18 juli 2026
Product- en aanbiedersregisters zijn gescheiden

Nederlandse gids voor controle in de Geneesmiddeleninformatiebank, de overheidsroute voor online aanbieders, de receptstatus en de identiteit achter een peptideaanbod.

Comparison mode
EUR / CBG- en overheidsregisters voor aanbieders
Current price coverage
Geen gekwalificeerde Nederlandse aanbiederstabel
Read the Nederland guide
07

Peptides in Switzerland (Peptide Schweiz)

English · July 18, 2026
Swissmedic and cantonal checks required

A Switzerland-specific guide to using Swissmedic's authorized-medicine lists, official product information, and internet-medicine guidance before reviewing a peptide offer.

Comparison mode
CHF / Swissmedic and cantonal verification
Current price coverage
No qualified Switzerland seller table
Read the Switzerland guide
08

Peptydy w Polsce

Polski · 18 lipca 2026
Rejestr leku i apteki muszą się zgadzać

Polski poradnik weryfikacji leków związanych z peptydami w krajowym rejestrze oraz apteki internetowej przez oficjalne logo unijne i Rejestr Aptek.

Comparison mode
PLN / rejestry produktów URPL i Rejestr Aptek
Current price coverage
Brak zakwalifikowanej tabeli sprzedawców w Polsce
Read the Polska guide
09

Peptides in Ireland

English · July 18, 2026
HPRA product and PSI supplier checks

An Ireland guide to matching peptide-related medicines to HPRA authorization records and checking pharmacies, professionals, and internet suppliers in the live PSI registers.

Comparison mode
EUR / HPRA medicine and PSI supply records
Current price coverage
No qualified Ireland seller table
Read the Ireland guide
10

Péptidos em Portugal

Português (Portugal) · 18 de julho de 2026
Verificação no Infomed e de vendedor licenciado

Um guia de Portugal para verificar medicamentos relacionados com péptidos no Infomed e confirmar se uma farmácia ou site de entrega ao domicílio consta dos registos públicos de licenciamento do INFARMED.

Comparison mode
EUR / Registos do Infomed e de licenciamento do INFARMED
Current price coverage
Nenhuma tabela qualificada de vendedores em Portugal
Read the Portugal guide
11

Peptider i Sverige

Svenska · 18 juli 2026
Produkt- och apotekskontroll hos Läkemedelsverket

En svensk guide för att kontrollera peptidrelaterade produkter i det nationella läkemedelsregistret och jämföra ett apotek eller en webbsäljare med Läkemedelsverkets tillståndsuppgifter.

Comparison mode
SEK / Läkemedelsverkets produkt- och apoteksregister
Current price coverage
Ingen kvalificerad tabell över svenska säljare
Read the Sverige guide
12

Türkiye'de Peptitler

Türkçe · 18 Temmuz 2026
TİTCK ürün ve tedarik kayıtları ayrı kontrol edilmeli

Türkiye'de peptit, peptit ilacı, zayıflama ilacı veya araştırma materyali arayanlar için TİTCK ruhsatlı ürün ve ruhsatlı ecza ticarethanesi kayıtlarını birlikte kullanma rehberi. Aynı etken madde adı, Türkçe ürün sayfası veya Türkiye'ye teslimat vaadi tek başına ruhsat ya da yasal tedarik kanıtı değildir.

Comparison mode
TRY / TİTCK ruhsatlı ürün ve tedarik kayıtları
Current price coverage
Yayın standardını karşılayan Türkiye satıcı fiyat tablosu yok
Read the Türkiye guide
13

Peptide in Österreich

Deutsch · 18. Juli 2026
BASG-Produkt- und Bezugsquellenprüfung erforderlich

Ein österreichischer Leitfaden für Suchanfragen zu Peptiden, Peptidarzneimitteln, Gewichtsmanagement-Wirkstoffen und Forschungsmaterialien. Beginne im Arzneispezialitätenregister des BASG und prüfe danach die Apotheke, den Betrieb oder den Versandweg im passenden öffentlichen Register, statt aus einem Wirkstoffnamen oder einer Euro-Preisangabe auf eine zulässige Versorgung zu schließen.

Comparison mode
EUR / BASG-Arzneimittel- und Betriebsregister
Current price coverage
Keine qualifizierte österreichische Anbietertabelle
Read the Österreich guide
14

Peptiden in België

Nederlands · 18 juli 2026
FAGG-product- en apotheekcontrole vereist

Een Nederlandstalige gids voor zoekopdrachten naar peptiden, peptidegeneesmiddelen, middelen voor gewichtsbeheersing en onderzoeksmaterialen in België. Zoek eerst het exacte geneesmiddel in de databank van het FAGG en controleer daarna de openbare apotheek en haar website via de officiële internetapotheekroute, zonder taal, europrijs of Belgische bezorging als bewijs te behandelen.

Comparison mode
EUR / FAGG-geneesmiddelen- en internetapotheekrecords
Current price coverage
Geen gekwalificeerde Belgische verkoperstabel
Read the België guide
15

Peptider i Danmark

Dansk · 18. juli 2026
Produkt- og netapotekskontrol hos Lægemiddelstyrelsen

En dansk guide til søgninger efter peptider, peptidlægemidler, vægtregulerende stoffer og forskningsmaterialer. Brug Lægemiddelstyrelsens liste over godkendte lægemidler til det præcise produkt, og kontrollér derefter apoteket eller forhandleren i den officielle oversigt over lovligt onlinesalg, før et tilbud sammenlignes.

Comparison mode
DKK / Lægemiddelstyrelsens produkt- og onlineregistre
Current price coverage
Ingen kvalificeret dansk sælgertabel
Read the Danmark guide
16

Peptidit Suomessa

Suomi · 18. heinäkuuta 2026
Fimean tuote- ja verkkoapteekkivarmennus tarvitaan

Suomenkielinen opas peptidien, peptidilääkkeiden, painonhallintalääkkeiden ja tutkimusmateriaalien hakuihin. Tarkista ensin tarkka lääke Fimean lääkehausta tai Kelan lääketietokannasta ja varmista sen jälkeen verkkopalvelun taustalla oleva apteekki Fimean laillisten apteekin verkkopalvelujen luettelosta.

Comparison mode
EUR / Fimean lääke- ja verkkoapteekkirekisterit
Current price coverage
Ei julkaisukriteerit täyttävää Suomen myyjätaulukkoa
Read the Suomi guide
00
Publishing gate

No region-wide seller table yet.

Peptide Local will publish regional commercial comparisons only when every row has a sourced seller category, product status, destination market, comparable price, evidence route, and observation date. The current page compares official verification paths.

Continue the map